mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |